Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.

Correction: Olaparib not cost-effective as maintenance therapy for platinum-sensitive, BRCA1/2 germline-mutated metastatic pancreatic cancer.

[This corrects the article DOI: 10.1371/journal.pone.0301271.].

Saved in:
Bibliographic Details
Main Authors: Tarun Mehra, Judith E Lupatsch, Thibaud Koessler, Konstantin Dedes, Alexander Reinhard Siebenhüner, Roger von Moos, Andreas Wicki, Matthias E Schwenkglenks
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0315976
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items